Multiple studies are surfacing showing promise for Cannabis as a Covid-19 treatment. For example, we recently wrote about a study conducted by researchers from the University of Nebraska and the Texas Biomedical Research Institute. They are recommending more research into how cannabis-derived CBD might help treat dangerous lung inflammation from the novel coronavirus. The authors detailed the evidence for how cannabis’ anti-inflammatory powers may help in a peer reviewed article in this month’s issue of Brain, Behavior, and Immunity. You can read more about that here.
The latest study on the stubject from researchers at Augusta University in Georgia suggests that CBD may positively impact ARDS or acute respiratory distress syndrome – a dangerous symptom in COVID-19 caused by an overactive inflammatory response. This is sometimes referred to as a ‘cytokine storm’.
CBD may be able to help treat this dangerous symptom of COVID-19. The researchers suggest CBD may be able to help by reducing pro-inflammatory cytokine production, fighting off the storm. By reducing specific cytokines such as interleukin (IL)-6, IL-1b, and IL-17, we may be able to bring down the inflammation and thus end the respiratory distress and damage. And the results of these researchers’ experiments supported this theory.
You can read more about it here.
Researchers from the University of Lethbridge also put out a study in April showing 13 cannabis plants were high in CBD appeared to affect the ACE2 pathways that the virus uses to access the body “We were totally stunned at first, and then we were really happy,” one of the researchers, Olga Kovalchuk, told CTV News. CBD blocks proteins that provide a way for for COVID-19.
“Our work could have a huge influence — there aren’t many drugs that have the potential of reducing infection by 70 to 80 percent,” he told the Calgary Herald.